Aethlon Medical
AEMD
$1.32
Share price
-5.71%
Change (1 day)
266.67%
Change (1 year)
Categories
P/S ratio for Aethlon Medical (AEMD)
P/S ratio as of May 2024 (TTM): 6.04
According to Aethlon Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.04488. At the end of 2023 the company had a P/S ratio of 9.51.
P/S ratio history for Aethlon Medical from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.51 | -98.03% |
| 2022 | 482 | 430.41% |
| 2021 | 90.8 | 152.99% |
| 2020 | 35.9 | 308.33% |
| 2019 | 8.79 | -93.6% |
| 2018 | 137 | -39.74% |
| 2017 | 228 | 319.36% |
| 2016 | 54.4 | -7.5% |
| 2015 | 58.8 | -14.8% |
| 2014 | 69.0 | 156.33% |
| 2013 | 26.9 | 195.26% |
| 2012 | 9.12 | 50.5% |
| 2011 | 6.06 | |
| 2010 | N/A | |
| 2009 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 PerkinElmer
PKI | 4.31 | -28.77% | 🇺🇸 USA |
 Pacific Biosciences
PACB | 2.30 | -62.03% | 🇺🇸 USA |
 Coherent
COHR | 1.63 | -73.07% | 🇺🇸 USA |
 Bruker BRKR | 3.87 | -35.91% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | 1.68 | -72.20% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | 361 | 5,870.04% | 🇺🇸 USA |